TM1-O-08 Introduction: Phthalates are thought to be hormonally active in humans and exert reproductive toxicity. The general population is exposed to phthalates through nutrition, consumer products, and medical devices. The present study explored whether internal phthalate exposure can be related to parameters of semen quality (ie, concentration, motility, and morphology) and hormone status. Methods: We recruited 335 men who were part of subfertile couples and were referred to the Outpatients Department Centre of Dermatology and Andrology of the University of Giessen, Germany, for fertility workup between April 2004 and October 2005. Semen analysis was performed according to guidelines of the World Health Organization (WHO) using the revised Duesseldorf classification of sperm morphology. If necessary, parameters were dichotomized based on 1999 WHO reference values for sperm concentration (<20 million/mL) and motility (<50% motile), as well as Tygerberg strict criteria for morphology (<4% normal). In single spot urine secondary metabolites of DEHP, 5OH-MEHP, and 5oxo-MEHP next to the monoester metabolite MEHP and depending on volume of urine sample, other phthalate metabolites were analyzed (eg, MnBP, MBzBP, MBzP). Results: Concentrations of phthalate metabolites of n = 296 men (median age, 34 years; median body mass index, 25.99 kg/m2) entered analysis. Median concentrations (μg/L) were as follows: MEHP (n = 287), 4.91; MnBP (n = 249), 32.76; MBzBP (n = 137), 5.14; and MBzP (n = 111), 5.03. Semen parameters of n = 253 men entered analysis. Semen concentration (<20 million/mL (n = 279): 33.0%) or sperm motility (WHO A+B <50% [n = 266]: 24.8%) were not found to be associated neither with the secondary metabolites nor with MEHP (adjusted logistic and linear regression). Adjustment was performed for: age, time of abstinence, and smoking status. Tendencies found in preliminary evaluations for sperm morphology (<4% normal [n = 259]: 62.2%) did not turn to significant values in this larger sample. Semen concentrations and motility as well as hormone levels (n = 276) (median for FSH, 5.0 mU/mL; LH, 3.5 mU/mL; and testosterone, 3.5 ng/mL) were not related to concentrations of any metabolites. Conclusions: Metabolites of DEHP and other phthalates analyzed in the scope of this study are considered to be very specific for determining internal phthalate exposure. According to this evaluation fertility parameters, ie, hormones and semen analyses do not show significant associations with concentrations of phthalate metabolites determined in spot urine sampled at the day of fertility workup, ie, no indication of acute effects. Further analyses, aimed at studying middle-term effects will address associations between the phthalate concentrations presented here and fertility parameters assessed in the same men during a second consultation several weeks later.
Read full abstract